Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 1/6 |
Green Cross Holdings Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩14,800.00 |
52 Week High | ₩18,490.00 |
52 Week Low | ₩12,940.00 |
Beta | 0.91 |
11 Month Change | 2.49% |
3 Month Change | 4.37% |
1 Year Change | 8.74% |
33 Year Change | -55.35% |
5 Year Change | -23.32% |
Change since IPO | 798.00% |
Recent News & Updates
Recent updates
Is Green Cross Holdings (KRX:005250) Using Debt Sensibly?
Aug 09Know This Before Buying Green Cross Holdings Corporation (KRX:005250) For Its Dividend
Apr 28Is Now The Time To Put Green Cross Holdings (KRX:005250) On Your Watchlist?
Mar 21Green Cross Holdings (KRX:005250) Seems To Be Using A Lot Of Debt
Mar 01If You Had Bought Green Cross Holdings (KRX:005250) Stock A Year Ago, You Could Pocket A 106% Gain Today
Feb 12Here's What Green Cross Holdings Corporation's (KRX:005250) Shareholder Ownership Structure Looks Like
Jan 28We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings
Jan 12Green Cross Holdings Corporation (KRX:005250) Investors Should Think About This Before Buying It For Its Dividend
Dec 28Green Cross Holdings Corporation's (KRX:005250) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Dec 13Green Cross Holdings (KRX:005250) Use Of Debt Could Be Considered Risky
Nov 28Optimistic Investors Push Green Cross Holdings Corporation (KRX:005250) Shares Up 63% But Growth Is Lacking
Nov 28Shareholder Returns
A005250 | KR Biotechs | KR Market | |
---|---|---|---|
7D | -11.7% | -5.8% | -4.2% |
1Y | 8.7% | 28.1% | -2.7% |
Return vs Industry: A005250 underperformed the KR Biotechs industry which returned 28.1% over the past year.
Return vs Market: A005250 exceeded the KR Market which returned -2.7% over the past year.
Price Volatility
A005250 volatility | |
---|---|
A005250 Average Weekly Movement | 6.4% |
Biotechs Industry Average Movement | 9.4% |
Market Average Movement | 6.5% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A005250 has not had significant price volatility in the past 3 months.
Volatility Over Time: A005250's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1967 | 154 | Il-Sup Huh | www.gcbiopharma.com |
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille’s syndrome.
Green Cross Holdings Corporation Fundamentals Summary
A005250 fundamental statistics | |
---|---|
Market cap | ₩687.18b |
Earnings (TTM) | -₩75.85b |
Revenue (TTM) | ₩2.11t |
0.3x
P/S Ratio-8.9x
P/E RatioIs A005250 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A005250 income statement (TTM) | |
---|---|
Revenue | ₩2.11t |
Cost of Revenue | ₩1.52t |
Gross Profit | ₩595.08b |
Other Expenses | ₩670.93b |
Earnings | -₩75.85b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.67k |
Gross Margin | 28.16% |
Net Profit Margin | -3.59% |
Debt/Equity Ratio | 80.5% |
How did A005250 perform over the long term?
See historical performance and comparison